Andrew Fein
Stock Analyst at HC Wainwright & Co.
(4.54)
# 266
Out of 5,138 analysts
568
Total ratings
52.12%
Success rate
24.28%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KALV KalVista Pharmaceuticals | Maintains: Buy | $27 → $37 | $15.31 | +141.67% | 17 | Jan 9, 2026 | |
| AMLX Amylyx Pharmaceuticals | Maintains: Buy | $16 → $20 | $16.55 | +20.85% | 21 | Nov 7, 2025 | |
| ALEC Alector | Maintains: Buy | $10 → $5 | $1.83 | +173.22% | 11 | Oct 22, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $400 → $500 | $468.07 | +6.82% | 17 | Sep 5, 2025 | |
| BIIB Biogen | Maintains: Buy | $187 → $194 | $165.38 | +17.31% | 22 | Aug 1, 2025 | |
| FULC Fulcrum Therapeutics | Upgrades: Buy | $4 → $12 | $10.60 | +13.21% | 18 | Jul 29, 2025 | |
| CADL Candel Therapeutics | Assumes: Buy | $23 | $5.92 | +288.51% | 1 | Jun 30, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $54 → $60 | $68.14 | -11.95% | 8 | Jun 26, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $32 | $26.29 | +21.72% | 20 | Jun 26, 2025 | |
| VRTX Vertex Pharmaceuticals | Reiterates: Buy | $550 | $442.08 | +24.41% | 27 | Jun 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $163.51 | -26.61% | 15 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $5.95 | +34.45% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $6 → $2 | $5.97 | -66.50% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $35 | $39.36 | -11.08% | 14 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $14 | $9.25 | +51.35% | 18 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $35 | $28.72 | +21.87% | 14 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $14 | $6.16 | +127.27% | 16 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $91.02 | -17.60% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $68 | $72.46 | -6.16% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $16.58 | +129.19% | 12 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $25 | $18.43 | +35.65% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $32 | $17.53 | +82.54% | 22 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $6.67 | +349.78% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $16 | $20.89 | -23.41% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $24 | $12.03 | +99.50% | 19 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $3.32 | +261.45% | 16 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $98.01 | -61.23% | 6 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $168 | $134.54 | +24.87% | 20 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $11 | $1.86 | +491.40% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.87 | +248.43% | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $13.82 | +59.19% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $120 → $20 | $14.92 | +34.05% | 16 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $1.68 | +614.29% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $5.57 | +133.39% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.81 | +40.85% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $5.60 | +310.71% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.12 | +1,239.29% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $23.38 | +49.70% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $8.59 | +773.11% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $2.18 | +221.10% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.67 | +274.53% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.64 | +23,433.10% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $200 → $60 | $15.51 | +286.85% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $4.75 | +215.79% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $0.88 | +4,468.30% | 3 | Mar 16, 2022 |
KalVista Pharmaceuticals
Jan 9, 2026
Maintains: Buy
Price Target: $27 → $37
Current: $15.31
Upside: +141.67%
Amylyx Pharmaceuticals
Nov 7, 2025
Maintains: Buy
Price Target: $16 → $20
Current: $16.55
Upside: +20.85%
Alector
Oct 22, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.83
Upside: +173.22%
United Therapeutics
Sep 5, 2025
Maintains: Buy
Price Target: $400 → $500
Current: $468.07
Upside: +6.82%
Biogen
Aug 1, 2025
Maintains: Buy
Price Target: $187 → $194
Current: $165.38
Upside: +17.31%
Fulcrum Therapeutics
Jul 29, 2025
Upgrades: Buy
Price Target: $4 → $12
Current: $10.60
Upside: +13.21%
Candel Therapeutics
Jun 30, 2025
Assumes: Buy
Price Target: $23
Current: $5.92
Upside: +288.51%
Kymera Therapeutics
Jun 26, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $68.14
Upside: -11.95%
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $32
Current: $26.29
Upside: +21.72%
Vertex Pharmaceuticals
Jun 23, 2025
Reiterates: Buy
Price Target: $550
Current: $442.08
Upside: +24.41%
Jun 11, 2025
Maintains: Buy
Price Target: $90 → $120
Current: $163.51
Upside: -26.61%
May 29, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $5.95
Upside: +34.45%
May 29, 2025
Downgrades: Neutral
Price Target: $6 → $2
Current: $5.97
Upside: -66.50%
May 28, 2025
Maintains: Buy
Price Target: $29 → $35
Current: $39.36
Upside: -11.08%
May 27, 2025
Maintains: Buy
Price Target: $30 → $14
Current: $9.25
Upside: +51.35%
May 14, 2025
Maintains: Buy
Price Target: $47 → $35
Current: $28.72
Upside: +21.87%
May 14, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $6.16
Upside: +127.27%
May 12, 2025
Maintains: Buy
Price Target: $80 → $75
Current: $91.02
Upside: -17.60%
May 12, 2025
Maintains: Buy
Price Target: $72 → $68
Current: $72.46
Upside: -6.16%
May 9, 2025
Maintains: Buy
Price Target: $46 → $38
Current: $16.58
Upside: +129.19%
May 8, 2025
Maintains: Buy
Price Target: $40 → $25
Current: $18.43
Upside: +35.65%
May 7, 2025
Maintains: Buy
Price Target: $80 → $32
Current: $17.53
Upside: +82.54%
May 6, 2025
Reiterates: Buy
Price Target: $30
Current: $6.67
Upside: +349.78%
May 5, 2025
Maintains: Buy
Price Target: $7 → $16
Current: $20.89
Upside: -23.41%
May 2, 2025
Maintains: Buy
Price Target: $81 → $24
Current: $12.03
Upside: +99.50%
May 1, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $3.32
Upside: +261.45%
Apr 30, 2025
Reiterates: Buy
Price Target: $38
Current: $98.01
Upside: -61.23%
Apr 22, 2025
Maintains: Buy
Price Target: $185 → $168
Current: $134.54
Upside: +24.87%
Mar 28, 2025
Maintains: Buy
Price Target: $15 → $11
Current: $1.86
Upside: +491.40%
Mar 27, 2025
Reiterates: Buy
Price Target: $10
Current: $2.87
Upside: +248.43%
Mar 26, 2025
Reiterates: Buy
Price Target: $22
Current: $13.82
Upside: +59.19%
Mar 17, 2025
Downgrades: Neutral
Price Target: $120 → $20
Current: $14.92
Upside: +34.05%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $1.68
Upside: +614.29%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $5.57
Upside: +133.39%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $7.81
Upside: +40.85%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $5.60
Upside: +310.71%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $1.12
Upside: +1,239.29%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $23.38
Upside: +49.70%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $8.59
Upside: +773.11%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $2.18
Upside: +221.10%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $2.67
Upside: +274.53%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $0.64
Upside: +23,433.10%
May 5, 2022
Downgrades: Neutral
Price Target: $200 → $60
Current: $15.51
Upside: +286.85%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $4.75
Upside: +215.79%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $0.88
Upside: +4,468.30%